IMPROVEMENT IN RENAL FUNCTION IN A PATIENT WITH HEPATITIS C VIREMIA (HCV) ASSOCIATED CRYOGLOBULINEMIC MPGN AFTER NOVEL HCV TREATMENT

被引:0
|
作者
Komanduri, Krishna [1 ]
Yozviak, Joseph [1 ]
Kopyt, Nelson [1 ]
Verma, Vikram [1 ]
机构
[1] Lehigh Valley Hlth Network, Allentown, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
181
引用
收藏
页码:A64 / A64
页数:1
相关论文
共 50 条
  • [21] ANTI-GOR WITHOUT ANTI-HCV CORE IS NOT ASSOCIATED WITH HEPATITIS-C VIREMIA
    BAATH, L
    WIDELL, A
    VOX SANGUINIS, 1994, 66 (02) : 151 - 151
  • [22] Diffuse Alveolar Hemorrhage (DAH) in Hepatitis C Virus (HCV) Associated Cryoglobulinemia After Completion of HCV Therapy
    Singh, Abhijai
    Chuturvedula, Chandrakanta
    Gill, Gurbir
    Abraham, Reshma
    Malhotra, Pieusha
    CHEST, 2016, 150 (04) : 530A - 530A
  • [23] Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis
    Gragnani, Laura
    Lorini, Serena
    Martini, Lorenzo
    Stasi, Cristina
    Visentini, Marcella
    Petraccia, Luisa
    Marello, Niccolo
    Monti, Monica
    Marri, Silvia
    Madia, Francesco
    Ricca, Valdo
    Zignego, Anna Linda
    CLINICAL RHEUMATOLOGY, 2022, 41 (01) : 147 - 157
  • [24] Case of the HCV-associated immune thrombocytopenia in patient with chronic hepatitis C
    Ryabokon, Yu. Yu.
    PATHOLOGIA, 2012, (01): : 101 - 102
  • [25] Renal failure associated with hepatitis C virus infection - Improvement in renal function after treatment with interferon-alpha
    Moses, PL
    Krawitt, EL
    Aziz, W
    Corwin, HL
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (02) : 443 - 446
  • [26] Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
    Garcia-Broncano, Pilar
    Maria Medrano, Luz
    Berenguer, Juan
    Brochado-Kith, Oscar
    Gonzalez-Garcia, Juan
    Jimenez-Sousa, Angeles
    Quereda, Carmen
    Sanz, Jose
    Jesus Tellez, Maria
    Diaz, Laura
    Luis JImenez, Jose
    Resino, Salvador
    Carrero, A.
    Miralles, P.
    Lopez, J. C.
    Parras, F.
    Padilla, B.
    Aldamiz-Echevarria, T.
    Tejerina, F.
    Diez, C.
    Perez-Latorre, L.
    Fanciulli, C.
    Gutierrez, I
    Ramirez, M.
    Carretero, S.
    Bellon, J. M.
    Bermejo, J.
    Berenguer, J.
    Hontanon, V
    Arribas, J. R.
    Montes, M. L.
    Bernardino, I
    Pascual, J. F.
    Zamora, F.
    Pena, J. M.
    Arnalich, F.
    Diaz, M.
    Gonzalez-Garcia, J.
    Domingo, P.
    Guardiola, J. M.
    Van den Eynde, E.
    Perez, M.
    Ribera, E.
    Crespo, M.
    Casado, J. L.
    Dronda, F.
    Moreno, A.
    Perez-Elias, M. J.
    Sanfrutos, M. A.
    Moreno, S.
    JOURNAL OF INFECTION, 2020, 80 (01) : 99 - 110
  • [27] HCV-associated fibrosing cholestatic hepatitis (FCH) resolved by DAA treatment in a HIV/HCV-coninfected patient
    Schlabe, S.
    Schneeweiss, S.
    Schwarze-Zander, C.
    Fischer, H. -P.
    Zhou, H.
    Boesecke, C.
    Spengler, U.
    Rockstroh, J. K.
    HIV MEDICINE, 2021, 22 : 302 - 303
  • [28] Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient
    Rodriguez-Torres, Maribel
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (10) : 1117 - 1128
  • [29] COMPLETE RECOVERY OF KIDNEY ALLOGRAFT FUNCTION AFTER RECURRENCE OF HCV RELATED MPGN: A CASE OF SUCCESSFUL ANTIVIRAL TREATMENT OF HCV IN A KIDNEY ALLOGRAFT RECIPIENT REQUIRING HEMODIALYSIS
    Schrezenmeier, Eva
    Halleck, Fabian
    Staeck, Oliver
    Khadzhynov, Dmytro
    Budde, Klemens
    Duerr, Michael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1580 - 1581
  • [30] Patient Reasons for Initiating or Delaying Hepatitis C Virus (HCV) Treatment and Physician Reasons for Selecting an HCV Treatment: A Prospective Observational Study
    Szabo, Shelagh M.
    Walker, David R.
    Juday, Timothy R.
    Lane, Suzanne
    Saab, Sammy
    HEPATOLOGY, 2015, 62 : 771A - 771A